University Of Melbourne
Clinical trials sponsored by University Of Melbourne, explained in plain language.
-
Could a second drug boost stroke recovery?
Disease control Recruiting nowThis study tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after mechanical clot removal helps people recover better from a severe stroke. About 462 adults with a large vessel occlusion stroke will be randomly assigned to receive either…
Phase: PHASE2, PHASE3 • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 26, 2026 02:06 UTC
-
New brain bleed surgery could save lives and improve recovery
Disease control Recruiting nowThis study tests a new, less invasive surgery to remove blood clots from the brain within 8 hours of a stroke caused by bleeding. About 240 adults with large brain bleeds will be randomly assigned to either the new surgery or standard medical care. The goal is to see if the surge…
Phase: NA • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 26, 2026 02:06 UTC
-
Could a brace replace surgery for torn ACLs?
Disease control Recruiting nowThis study tests if a special 12-week knee brace program works as well as surgery for people with a torn ACL. About 180 active adults aged 16-40 will be randomly assigned to either the brace or surgery group. Both groups will do physical therapy, and researchers will track knee p…
Phase: NA • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 26, 2026 02:00 UTC
-
New hope for deadly stroke: drug may restore blood flow hours later
Disease control Recruiting nowThis study tests a clot-busting drug called tenecteplase in people who have a severe stroke caused by a blockage in the main artery at the back of the brain. The goal is to see if giving this drug within 24 hours of symptoms can improve recovery and reduce disability. About 688 a…
Phase: PHASE2, PHASE3 • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 26, 2026 01:58 UTC
-
Massive global trial aims to slash deaths from staph blood infections
Disease control Recruiting nowThis large international trial is testing different treatments to lower the risk of death in people with a serious staph bloodstream infection. Up to 8,000 hospitalized adults will receive one of several experimental therapies. The main goal is to see which treatments improve sur…
Phase: PHASE4 • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Can a cancer drug help flush out hidden HIV?
Disease control Recruiting nowThis study is testing whether a single low dose of nivolumab, a drug used in cancer treatment, can reduce the hidden HIV reservoir in people living with HIV who are on antiretroviral therapy (ART). The HIV reservoir is a group of infected cells that stay dormant and prevent a cur…
Phase: PHASE1, PHASE2 • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
IBS showdown: cut out foods or face your fears online?
Symptom relief Recruiting nowThis study compares two online treatments for Irritable Bowel Syndrome (IBS): a low-FODMAP diet that cuts out certain carbs, and exposure-based cognitive behavioral therapy that helps change unhelpful behaviors. Researchers want to find out which treatment works best for differen…
Phase: NA • Sponsor: University of Melbourne • Aim: Symptom relief
Last updated May 26, 2026 02:06 UTC
-
New study aims to predict and prevent thunderstorm asthma outbreaks
Knowledge-focused Recruiting nowThis study is for adults with hay fever living in South-Eastern Australia. Researchers want to find out who is most at risk for thunderstorm asthma, a dangerous condition that happens during spring pollen season. Participants will be tested for grass pollen allergy, do simple bre…
Phase: NA • Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated May 26, 2026 01:59 UTC